Live Cell Imaging Market To Reach USD 3.76 Billion By 2026 | Reports And Data
27 août 2019 12h03 HE
|
Reports and Data
New York, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Factors contributing to the growing CAGR are rising incidences of cancer, diabetes and cardiovascular disorders worldwide, adoption of high-content...
GenCure announces breakthrough first run of 80-liter bioreactor
13 août 2019 09h10 HE
|
BioBridge Global
San Antonio, Texas, Aug. 13, 2019 (GLOBE NEWSWIRE) -- In a breakthrough for the regenerative medicine industry, GenCure announced today that its biomanufacturing services team has successfully...
Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
18 juil. 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the...
Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery
02 juil. 2019 08h30 HE
|
Hemostemix Inc.
CALGARY, Alberta, July 02, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company developing and commercializing...
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.
02 juil. 2019 02h47 HE
|
Esperite N.V.
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE. ...
Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
27 juin 2019 08h30 HE
|
Hemostemix Inc.
CALGARY, Alberta, June 27, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has enrolled a total of forty (40)...
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease
30 mai 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
6th annual Regenerative Medicine Essentials Course Set for June 10 - 14.
13 mai 2019 10h01 HE
|
Regenerative Medicine Foundation
Winston-Salem, NC, May 13, 2019 (GLOBE NEWSWIRE) -- WINSTON-SALEM, NC – The sixth annual Regenerative Medicine Essentials Course will be held June 10 - 14 in downtown Winston-Salem. The course is...
Hemostemix Announces Convertible Debenture Financing
15 avr. 2019 08h30 HE
|
Hemostemix Inc.
NOT FOR DISTRIBTUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 15, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...
Leapsmag and the Regenerative Medicine Foundation launch video series “The Future Is Now: The Revolutionary Power of Stem Cell Research"
03 avr. 2019 15h01 HE
|
Regenerative Medicine Foundation
Los Angeles, CA, April 03, 2019 (GLOBE NEWSWIRE) -- Leapsmag, the online magazine showcasing groundbreaking advances in the life sciences, and the Regenerative Medicine Foundation (RMF) have...